Sun Pharma to aquire US based Krystal Biotech
Sun Pharma to aquire US based Krystal Biotech in 7 million USD. Krystal Biotech is a biopharmaceutical company using gene therapy to develop treatments for patients suffering from rare debilitating disorders.
[adsense:336x280:8701650588]
Last month, it had invested Rs 85.5 crore in Zenotech Laboratories Ltd to raise its stake in the Hyderabad-based company. In March, the company had agreed to acquire Canadian pharmaceuticals firm Thallion Pharmaceuticals for about million.
Sun Pharma to gave cash consideration of USD 7 million which would be paid for acquisition of Shares and Shares are being acquired at USD 34.46 per share.